CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) Stock Fundamental Analysis
USA - NASDAQ:CCLDO - US14167R3084
21.1 USD
-0.23 (-1.08%)
CCLDO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. CCLDO has an average financial health and profitability rating. CCLDO is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CCLDO had negative earnings in the past year.
CCLDO had a positive operating cash flow in the past year.
In the past 5 years CCLDO always reported negative net income.
Of the past 5 years CCLDO 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CCLDO (0.02%) is better than 80.00% of its industry peers.
CCLDO's Return On Equity of 0.02% is fine compared to the rest of the industry. CCLDO outperforms 80.00% of its industry peers.
CCLDO has a Return On Invested Capital of 16.12%. This is amongst the best in the industry. CCLDO outperforms 94.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.02% | ||
| ROIC | 16.12% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.01%, CCLDO is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
CCLDO has a Operating Margin of 10.77%. This is amongst the best in the industry. CCLDO outperforms 85.71% of its industry peers.
CCLDO's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 46.00%, CCLDO is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CCLDO has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.77% | ||
| PM (TTM) | 0.01% | ||
| GM | 46% |
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
2. Health
2.1 Basic Checks
CCLDO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CCLDO has more shares outstanding
Compared to 5 years ago, CCLDO has more shares outstanding
CCLDO has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 29.36 indicates that CCLDO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 29.36, CCLDO belongs to the top of the industry, outperforming 97.14% of the companies in the same industry.
CCLDO has a debt to FCF ratio of 0.02. This is a very positive value and a sign of high solvency as it would only need 0.02 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.02, CCLDO belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that CCLDO is not too dependend on debt financing.
CCLDO has a better Debt to Equity ratio (0.00) than 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.02 | ||
| Altman-Z | 29.36 |
ROIC/WACC1.63
WACC9.89%
2.3 Liquidity
A Current Ratio of 1.91 indicates that CCLDO should not have too much problems paying its short term obligations.
CCLDO has a worse Current ratio (1.91) than 60.00% of its industry peers.
CCLDO has a Quick Ratio of 1.88. This is a normal value and indicates that CCLDO is financially healthy and should not expect problems in meeting its short term obligations.
CCLDO's Quick ratio of 1.88 is on the low side compared to the rest of the industry. CCLDO is outperformed by 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.88 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 95.70% over the past year.
The Revenue has been growing slightly by 0.04% in the past year.
Measured over the past years, CCLDO shows a quite strong growth in Revenue. The Revenue has been growing by 11.47% on average per year.
EPS 1Y (TTM)95.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
Revenue 1Y (TTM)0.04%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%-2.54%
3.2 Future
The Earnings Per Share is expected to grow by 66.79% on average over the next years. This is a very strong growth
Based on estimates for the next years, CCLDO will show a quite strong growth in Revenue. The Revenue will grow by 11.66% on average per year.
EPS Next Y140.8%
EPS Next 2Y66.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.08%
Revenue Next 2Y11.66%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
CCLDO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 134.91, the valuation of CCLDO can be described as expensive.
CCLDO's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.23. CCLDO is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 134.91 |
4.2 Price Multiples
65.71% of the companies in the same industry are more expensive than CCLDO, based on the Enterprise Value to EBITDA ratio.
CCLDO's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 51.28 | ||
| EV/EBITDA | 35.36 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CCLDO's earnings are expected to grow with 66.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.79%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CCLDO has a Yearly Dividend Yield of 9.45%, which is a nice return.
Compared to an average industry Dividend Yield of 4.96, CCLDO pays a better dividend. On top of this CCLDO pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, CCLDO pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 9.45% |
5.2 History
On average, the dividend of CCLDO grows each year by 21.20%, which is quite nice.
CCLDO has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)21.2%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The dividend of CCLDO is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2Y66.79%
EPS Next 3YN/A
CARECLOUD INC - CCLD 8 3/4 PERP
NASDAQ:CCLDO (10/22/2025, 11:59:25 AM)
21.1
-0.23 (-1.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners19.86%
Inst Owner ChangeN/A
Ins Owners14.48%
Ins Owner ChangeN/A
Market Cap892.95M
Revenue(TTM)111.79M
Net Income(TTM)14.00K
Analysts80
Price Target30.86 (46.26%)
Short Float %0.01%
Short Ratio0.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 9.45% |
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.82%
Min EPS beat(2)21.57%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)72.28%
Min EPS beat(4)21.57%
Max EPS beat(4)100%
EPS beat(8)5
Avg EPS beat(8)-0.12%
EPS beat(12)8
Avg EPS beat(12)-1.47%
EPS beat(16)12
Avg EPS beat(16)11.57%
Revenue beat(2)1
Avg Revenue beat(2)2.17%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)5.6%
Revenue beat(4)1
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-1.89%
Max Revenue beat(4)5.6%
Revenue beat(8)1
Avg Revenue beat(8)-2.29%
Revenue beat(12)1
Avg Revenue beat(12)-3.19%
Revenue beat(16)3
Avg Revenue beat(16)-2.21%
PT rev (1m)11.28%
PT rev (3m)-20.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.72%
EPS NY rev (1m)-22.58%
EPS NY rev (3m)-20%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.21%
Revenue NY rev (1m)1.45%
Revenue NY rev (3m)4.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 134.91 | ||
| P/S | 7.99 | ||
| P/FCF | 51.28 | ||
| P/OCF | 35.99 | ||
| P/B | 15.92 | ||
| P/tB | 41.78 | ||
| EV/EBITDA | 35.36 |
EPS(TTM)-0.04
EYN/A
EPS(NY)0.16
Fwd EY0.74%
FCF(TTM)0.41
FCFY1.95%
OCF(TTM)0.59
OCFY2.78%
SpS2.64
BVpS1.33
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.02% | ||
| ROCE | 20.4% | ||
| ROIC | 16.12% | ||
| ROICexc | 16.12% | ||
| ROICexgc | 39.14% | ||
| OM | 10.77% | ||
| PM (TTM) | 0.01% | ||
| GM | 46% | ||
| FCFM | 15.58% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y52.71%
ROICexgc growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score7
Asset Turnover1.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.02 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 54.79% | ||
| Cap/Sales | 6.62% | ||
| Interest Coverage | 63.03 | ||
| Cash Conversion | 97.14% | ||
| Profit Quality | 124386% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.88 | ||
| Altman-Z | 29.36 |
F-Score7
WACC9.89%
ROIC/WACC1.63
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
EPS Next Y140.8%
EPS Next 2Y66.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.04%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%-2.54%
Revenue Next Year5.08%
Revenue Next 2Y11.66%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15735.1%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year209.54%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y112.11%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y21.45%
OCF growth 3Y15.69%
OCF growth 5Y22.06%